Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000912282-11-000007
Filing Date
2011-01-10
Accepted
2011-01-10 15:41:30
Documents
8
Effectiveness Date
2011-01-10

Document Format Files

Seq Description Document Type Size
1 oncolyticss8_012011.htm S-8 87287
2 AMENDED AND RESTATED STOCK OPTION PLAN ex4_1.htm EX-4.1 92310
3 OPINION OF MCCARTHY TETRAULT LLP ex5_1.htm EX-5.1 2259
4 CONSENT OF ERNST & YOUNG LLP ex23_1.htm EX-23.1 1463
5 oncolytics_logo.jpg GRAPHIC 12620
6 OPINION ex5_1p1.jpg GRAPHIC 136843
7 AUDITOR'S CONSENT ex23_1.jpg GRAPHIC 76749
8 ex5_1p2.jpg GRAPHIC 90690
  Complete submission text file 0000912282-11-000007.txt   621894
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-171625 | Film No.: 11520130
SIC: 2834 Pharmaceutical Preparations